ARTICLE | Clinical News
IV Factor VIIa-CTP: Phase IIa started
February 29, 2016 8:00 AM UTC
Opko began an open-label, dose-escalation, U.S. Phase IIa trial to evaluate single doses of IV Factor VIIa-CTP in about 24 adult male patients. Later this year, Opko plans to start a Phase IIa trial o...